What is the purpose of this trial?
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
Ages: 18 years and older
Eastern Cooperative Oncology Group
Start Date: 12/12/2017
End Date: 09/01/2021
Last Updated: 02/22/2018
Study HIC#: 1607018080